{
    "clinical_study": {
        "@rank": "142821", 
        "arm_group": [
            {
                "arm_group_label": "phenolic acids", 
                "arm_group_type": "Experimental", 
                "description": "Maltodextrine + Phenolic acids"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Maltodextrine"
            }, 
            {
                "arm_group_label": "phenolic acid", 
                "arm_group_type": "Experimental", 
                "description": "Maltodextrine + Phenolic acids"
            }, 
            {
                "arm_group_label": "polyphenol", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Epidemiological studies suggest dietary (poly) phenols decrease the risk of death from\n      cardiovascular diseases. (Poly)phenol-rich foods include fruits and vegetables as well as\n      tea, coffee, red wine, and chocolate. The aim of the present study is to investigate whether\n      endothelial function is altered by ingestion of phenolic acids. Moreover, the investigators\n      will evaluate the effect of phenolic acids on blood pressure and platelet adhesion."
        }, 
        "brief_title": "Effects of Phenolic Acids on Endothelial Function", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy\n\n          -  males\n\n          -  Smokers\n\n        Exclusion Criteria:\n\n        Any food allergy\n\n          -  Abnormal blood pressure defined as follow: systolic <100 or >160 mmHg and diastolic\n             <50 or >100mmHg\n\n          -  Regular consumption of medication within 2 months before the study inclusion\n\n          -  Caffeine intake 1 day before screening measurements (and 1 day before each visit),\n\n          -  Any intake of multivitamin-tablets and other supplemental compounds 10 days before\n             the study start and throughout the study.\n\n          -  Excessive alcohol intake defined as > 280 g per week"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01772784", 
            "org_study_id": "11.36.NRC"
        }, 
        "intervention": {
            "arm_group_label": [
                "phenolic acids", 
                "placebo", 
                "phenolic acid", 
                "polyphenol"
            ], 
            "description": "Phenolic acids", 
            "intervention_name": "Phenolic acids", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "subjects", 
        "lastchanged_date": "January 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bern", 
                    "country": "Switzerland", 
                    "zip": "3010"
                }, 
                "name": "Swiss Cardiovascular Center Bern, University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "4", 
        "overall_official": {
            "affiliation": "University Hospital, Bern, Switzerland", 
            "last_name": "Yves Allemann, MD, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "endothelial dysfunction", 
            "safety_issue": "No", 
            "time_frame": "1 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01772784"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}